AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE in Malawi
3 products registered with PMRA — 0 active, 3 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR_LAMIVUDINE&_TDF 50/300/300MG TABLET TABLET | PMPB/PL272/46 | — | expired | 31 Mar 2025 |
| DOLUTEGRAVIR_LAMIVUDINE_TDF 300MG TABLET TABLET | PMPB/PL493/1 | — | expired | 31 Mar 2025 |
| DOLUTEGRAVIR_LAMIVUDINE_TDF 50/300/300MG TABLET TABLET | PMPB/PL438/7 | — | expired | 31 Mar 2024 |
DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE — PMRA Registration Details
PMRA (Malawi) has 3 registered products containing DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.